Cargando…
Hepatic Macrophage as a Key Player in Fatty Liver Disease
Fatty liver disease, characterized by excessive inflammation and lipid deposition, is becoming one of the most prevalent liver metabolic diseases worldwide owing to the increasing global incidence of obesity. However, the underlying mechanisms of fatty liver disease are poorly understood. Accumulati...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696173/ https://www.ncbi.nlm.nih.gov/pubmed/34956171 http://dx.doi.org/10.3389/fimmu.2021.708978 |
_version_ | 1784619748281024512 |
---|---|
author | Xu, Liyun Liu, Wen Bai, Fuxiang Xu, Yong Liang, Xiaohong Ma, Chunhong Gao, Lifen |
author_facet | Xu, Liyun Liu, Wen Bai, Fuxiang Xu, Yong Liang, Xiaohong Ma, Chunhong Gao, Lifen |
author_sort | Xu, Liyun |
collection | PubMed |
description | Fatty liver disease, characterized by excessive inflammation and lipid deposition, is becoming one of the most prevalent liver metabolic diseases worldwide owing to the increasing global incidence of obesity. However, the underlying mechanisms of fatty liver disease are poorly understood. Accumulating evidence suggests that hepatic macrophages, specifically Kupffer cells (KCs), act as key players in the progression of fatty liver disease. Thus, it is essential to examine the current evidence of the roles of hepatic macrophages (both KCs and monocyte-derived macrophages). In this review, we primarily address the heterogeneities and multiple patterns of hepatic macrophages participating in the pathogenesis of fatty liver disease, including Toll-like receptors (TLRs), NLRP3 inflammasome, lipotoxicity, glucotoxicity, metabolic reprogramming, interaction with surrounding cells in the liver, and iron poisoning. A better understanding of the diverse roles of hepatic macrophages in the development of fatty liver disease may provide a more specific and promising macrophage-targeting therapeutic strategy for inflammatory liver diseases. |
format | Online Article Text |
id | pubmed-8696173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86961732021-12-24 Hepatic Macrophage as a Key Player in Fatty Liver Disease Xu, Liyun Liu, Wen Bai, Fuxiang Xu, Yong Liang, Xiaohong Ma, Chunhong Gao, Lifen Front Immunol Immunology Fatty liver disease, characterized by excessive inflammation and lipid deposition, is becoming one of the most prevalent liver metabolic diseases worldwide owing to the increasing global incidence of obesity. However, the underlying mechanisms of fatty liver disease are poorly understood. Accumulating evidence suggests that hepatic macrophages, specifically Kupffer cells (KCs), act as key players in the progression of fatty liver disease. Thus, it is essential to examine the current evidence of the roles of hepatic macrophages (both KCs and monocyte-derived macrophages). In this review, we primarily address the heterogeneities and multiple patterns of hepatic macrophages participating in the pathogenesis of fatty liver disease, including Toll-like receptors (TLRs), NLRP3 inflammasome, lipotoxicity, glucotoxicity, metabolic reprogramming, interaction with surrounding cells in the liver, and iron poisoning. A better understanding of the diverse roles of hepatic macrophages in the development of fatty liver disease may provide a more specific and promising macrophage-targeting therapeutic strategy for inflammatory liver diseases. Frontiers Media S.A. 2021-12-09 /pmc/articles/PMC8696173/ /pubmed/34956171 http://dx.doi.org/10.3389/fimmu.2021.708978 Text en Copyright © 2021 Xu, Liu, Bai, Xu, Liang, Ma and Gao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Xu, Liyun Liu, Wen Bai, Fuxiang Xu, Yong Liang, Xiaohong Ma, Chunhong Gao, Lifen Hepatic Macrophage as a Key Player in Fatty Liver Disease |
title | Hepatic Macrophage as a Key Player in Fatty Liver Disease |
title_full | Hepatic Macrophage as a Key Player in Fatty Liver Disease |
title_fullStr | Hepatic Macrophage as a Key Player in Fatty Liver Disease |
title_full_unstemmed | Hepatic Macrophage as a Key Player in Fatty Liver Disease |
title_short | Hepatic Macrophage as a Key Player in Fatty Liver Disease |
title_sort | hepatic macrophage as a key player in fatty liver disease |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696173/ https://www.ncbi.nlm.nih.gov/pubmed/34956171 http://dx.doi.org/10.3389/fimmu.2021.708978 |
work_keys_str_mv | AT xuliyun hepaticmacrophageasakeyplayerinfattyliverdisease AT liuwen hepaticmacrophageasakeyplayerinfattyliverdisease AT baifuxiang hepaticmacrophageasakeyplayerinfattyliverdisease AT xuyong hepaticmacrophageasakeyplayerinfattyliverdisease AT liangxiaohong hepaticmacrophageasakeyplayerinfattyliverdisease AT machunhong hepaticmacrophageasakeyplayerinfattyliverdisease AT gaolifen hepaticmacrophageasakeyplayerinfattyliverdisease |